LifePro Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

LifePro Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$447K	Sell	4,524 -266	-6%	-$26.1K	0.27%	85
2024 Q2	$444K	Sell	4,790 -465	-9%	-$41.7K	0.32%	69
2024 Q1	$499K	Sell	5,255 -77	-1%	-$7.14K	0.33%	67
2023 Q4	$476K	Buy	5,332 +272	+5%	+$20.2K	0.37%	62
2023 Q3	$369K	Buy	5,060 +1,908	+61%	+$152K	0.3%	67
2023 Q2	$262K	Sell	3,152 -1,116	-26%	-$93.3K	0.2%	88
2023 Q1	$354K	Hold	4,268	–	–	0.26%	75
2022 Q4	$354K	Sell	4,268 -1,988	-32%	-$161K	0.26%	75
2022 Q3	$496K	Sell	6,256 -94,605	-94%	-$7.98M	0.29%	38
2022 Q2	$7.49M	Buy	+100,861	New	+$7.57M	3.88%	1

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

LifePro Asset Management's XBI Position: Q3 2024 in Review

LifePro Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5.6% in Q3 2024, selling an estimated $26.1K and leaving 4,524 shares worth $447K. The position accounts for 0.27% of the portfolio, ranked #85.

LifePro Asset Management first reported a position in XBI in Q2 2022 and has held it in 10 quarters since. The position peaked at $7.49M in Q2 2022. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

LifePro Asset Management held 4,524 shares of State Street SPDR S&P Biotech ETF worth $447K as of Q3 2024.
LifePro Asset Management sold 266 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $26.1K.
State Street SPDR S&P Biotech ETF made up 0.27% of LifePro Asset Management's portfolio in Q3 2024, its #85 holding.
LifePro Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 10 quarters since.
LifePro Asset Management's State Street SPDR S&P Biotech ETF position peaked at $7.49M in Q2 2022.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on LifePro Asset Management's 13F filing for Q3 2024, filed 9 Oct 2024.